Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients

Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients

To estimate protection from <i>cytomegalovirus</i> (CMV) replication after solid organ transplantation, CMV serology has been considered insufficient and thus CMV immunity is increasingly assessed by cellular in vitro methods. We compared two commercially available IFN-γ ELISpot assays (...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Smaranda Gliga, Melanie Fiedler, Theresa Dornieden, Anne Achterfeld, Andreas Paul, Peter A. Horn, Kerstin Herzer, Monika Lindemann
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2021-01-01
Sarja:Vaccines
Aiheet:
human <i>cytomegalovirus</i>
reactivation
ELISpot
ELISA
interferon-γ
liver transplantation
Linkit:https://www.mdpi.com/2076-393X/9/2/88

Internet

https://www.mdpi.com/2076-393X/9/2/88

Samankaltaisia teoksia